Page 2 - Prtk News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Prtk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Prtk Today - Breaking & Trending Today
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Several other equities research analysts have also issued reports on the stock. HC Wainwright lowered shares of Paratek Pharmaceuticals […] ....
StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of several other reports. HC Wainwright downgraded shares of Paratek Pharmaceuticals from a buy rating to a neutral rating […] ....
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities research analysts have also weighed in on PRTK. HC Wainwright lowered Paratek Pharmaceuticals from a buy rating to […] ....
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a report published on Friday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Several other research firms have also commented on PRTK. BTIG Research reduced their price target on Paratek Pharmaceuticals from $24.00 to $5.00 in a […] ....
StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. A number of other equities analysts have also recently weighed in on the stock. HC Wainwright cut shares of Paratek Pharmaceuticals from […] ....